NASDAQ : MDWD

MediWound Ltd. — Company profile

Healthcare · Biotechnology · Israel

Last price 13.3 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 171.71M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Details

NameMediWound Ltd.
SectorHealthcare
IndustryBiotechnology
Employees121
Founded2000
Ipo Date2014-03-20
CeoOfer Gonen
CountryIsrael
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinIL0011316309
CusipM68830112
Cik0001593984
Sic2833

Key executives

NameTitle
Ofer Gonen B.Sc.Chief Executive Officer
Hani LuxenburgChief Financial Officer
Dr. Shmulik Hess Ph.D.Chief Operating Officer and Chief Commercial Officer
Yaron Meyer Adv.Executive Vice President, General Counsel and Corporate Secretary
Dr. Ety Klinger MBA, Ph.D.Chief Medical Officer
Dr. Liron GalVice President of Manufacturing Science and Technology
Barry J. WolfensonExecutive Vice President of Strategy and Corporate Development
Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc.Senior Vice President of Global Medical Affairs

Contact

Address42 Hayarkon Street, Yavne, 8122745, Israel
Phone972 7 797 14100
Websitehttps://www.mediwound.com